![]() ![]() Christa CobbaertĬonfounded Lp(a) test results masked clinical utility of Lp(a) test for decades Understanding the antithrombin measurand using an MS-based antithrombin proteoform methodĪn additional layer of clinical information beyond the imperfect total PSA: challenges and opportunities for GLY-PSA?Īdopting the metrological traceability and commutability concepts into quantitative proteomics applications right from the start: the serum apolipoprotein profile exampleĬhairs: Prof. Generating a New Hypothesis: Targeted Proteomics, Apolipoprotein L1, and Chronic Kidney Disease Predefining clinical performance specifications for potentially useful tests for colorectal cancer screening, as addition to the current iFOBTĮxploring the potential of (glyco-)proteoforms as future medical tests by means of enabling technologyĬhairs: Prof. The researcher's rationale for selecting a multiplexed biomarker panel for kidney injury based on clinical chemistry needs The nephrologist viewpoints regarding desirable urine diagnostic support & clinical pathways for reducing kidney injury in secondary and tertiary care hospitals This symposium is sponsered by Roche Diagnostics Nederland B.V and Sysmex Belgium N.V.īasics and key components of the EFLM Test Evaluation frameworkĮssentials of the EFLM Test Evaluation framework in the era of IVDR 2017/746Īpplying the basics for test (panel) selection and clinical pathway redesignĬhairs: Prof. ![]() The lectures will be given by renowned speakers in the field of Test Evaluation, Test Standardization and Clinical Proteomics. The symposium is a collaboration between Boerhaave Continuing Medical Education and the Department of Clinical Chemistry and Laboratory Medicine of the Leiden University Medical Center (LUMC). Translational Researchers, clinicians and IVD-manufacturers interested and involved in the biomarker-test pipeline.Laboratory Specialists in Clinical Chemistry and Hematology.Laboratory Specialist Trainees in Clinical Chemistry and Hematology.Developing network skills for collaboration between clinicians, laboratory professionals, IVD-industry and basic scientists.Identifying a feasible role as end-user in the biomarker-test development pipeline, in line with the abilities in your hospital setting.Demonstrating young trainees in laboratory medicine how to develop medical leadership skills in focus areas of innovation, enabling technology and/or data science.Guiding test evaluation according to the EFLM Test Evaluation framework.Demonstrating (multiplex) test selection and deducing future clinical pathways based on unmet needs.Applying a structured questionnaire for identifying unmet clinical needs in laboratory medicine, in line with 21st century precision medicine demands.Another important objective of the symposium is to bring clinical chemistry laboratory specialists together with other stakeholders of the biomarker - medical test pipeline. In addition to this, we will discuss the positioning of medical tests in clinical care pathways and to the generation of clinical evidence. We will address the clinical needs question during the symposium. To contribute to patient care in an efficient and effective way, it is important to rationalize the clinical needs. Do you want to know more? Please register timely via the registration link on this page. The potential of precision diagnostics is also examined. How do laboratory specialists and medical laboratories contribute to better patient outcome and more effective treatment? During this symposium we define health and disease at a molecular level on the basis of Clinical Proteomics. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |